Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epigenetic inactivation of DLX4 is associated with disease progression in chronic myeloid leukemia

15 Jun 2015

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Chronic Myeloid Leukemia Treatments
Share to Epigenetics and DNA Methylation

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 26086097
DOI: 10.1016/j.bbrc.2015.06.095

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epigenetic inactivation of DLX4 is associated with disease progression in chronic myeloid leukemiaPMID 26086097Read ↗

Identification and validation of prognosis‐related DLX5 methylation as an epigenetic driver in myeloid neoplasmsSemantic proximity Read ↗

ID4 methylation predicts high risk of leukemic transformation in patients with myelodysplastic syndromeSemantic proximity Read ↗

DLX4 hypermethylation is a prognostically adverse indicator in de novo acute myeloid leukemia.Semantic proximity Read ↗

Epigenetics in Acute Myeloid LeukemiaSemantic proximity Read ↗

Epigenetic deregulation in chronic lymphocytic leukemia: Clinical and biological impactSemantic proximity Read ↗

Cdx4 dysregulates <i>Hox</i> gene expression and generates acute myeloid leukemia alone and in cooperation with Meis1a in a murine modelSemantic proximity Read ↗

KDM6 and KDM4 histone lysine demethylases emerge as molecular therapeutic targets in human acute myeloid leukemiaSemantic proximity Read ↗

Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemiaSemantic proximity Read ↗

Whole exome sequencing identifies novel mutations of epigenetic regulators in chemorefractory pediatric acute myeloid leukemiaSemantic proximity Read ↗

Hypermethylation of DLX4 predicts poor clinical outcome in patients with myelodysplastic syndrome.Semantic proximity Read ↗

Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLLSemantic proximity Read ↗

Id2 and E Proteins Orchestrate the Initiation and Maintenance of MLL-Rearranged Acute Myeloid LeukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.